Greenfield, IN, United States of America

Guanmin Wu

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Elanco US Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guanmin Wu. Retrieved from https://idiyas.com/inventor/guanmin-wu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Guanmin Wu

Introduction

Guanmin Wu is an accomplished inventor based in Greenfield, IN (US). He has made significant contributions to the field of chemistry, particularly in the development of isoxazoline compounds. His work has led to advancements that enhance the purity and effectiveness of these compounds.

Latest Patents

Guanmin Wu holds a patent for a process for making an isoxazoline compound and its intermediate. The patent details processes for creating enantiomerically pure isoxazoline compounds, specifically improving the enantiomeric purity of 3-methyl-5-[(5S)-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]thiophene-2-carboxylic acid through crystallization. This innovation is crucial for applications in pharmaceuticals and agrochemicals.

Career Highlights

Wu is currently employed at Elanco US Inc., a company known for its focus on animal health and agricultural solutions. His role at Elanco allows him to apply his expertise in chemistry to develop products that improve animal health and productivity.

Collaborations

Guanmin Wu has collaborated with notable colleagues, including Jean Marie Defauw and Jingdan Hu. These partnerships have fostered a collaborative environment that enhances innovation and research within the company.

Conclusion

Guanmin Wu's contributions to the field of chemistry, particularly through his patent on isoxazoline compounds, demonstrate his commitment to innovation and excellence. His work at Elanco US Inc. continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…